Showing results (71-80 of 95) with videos related to
Sort By:
Pageof 10
Acta Neuropathologica Communications|February 5, 2021
Protein disulfide isomerase ERp57 protects early muscle denervation in experimental ALSPablo Rozas, Cristina Pinto, Francisca Martínez Traub, et al.Science Signaling|February 15, 2018
The unfolded protein response regulator ATF6 promotes mesodermal differentiationHeike Kroeger, Neil Grimsey, Ryan Paxman, et al.Biorxiv : the Preprint Server for Biology|September 18, 2025
General Trends in the Calnexin-Dependent Expression and Pharmacological Rescue of Clinical CFTR VariantsAustin Tedman, John A Olson, Minsoo Kim, et al.Expert Opinion on Drug Discovery|April 9, 2025
Recent developments in cystic fibrosis drug discovery: where are we today?Miquéias Lopes-Pacheco, Ashlyn G Winters, JaNise J Jackson, et al.Journal of the American Chemical Society|December 22, 2017
"Inverse Drug Discovery" Strategy To Identify Proteins That Are Targeted by Latent Electrophiles As Exemplified by Aryl FluorosulfatesDavid E Mortenson, Gabriel J Brighty, Lars Plate, et al.Elife|December 11, 2025
General trends in the calnexin-dependent expression and pharmacological rescue of clinical CFTR variantsAustin Tedman, John A Olson, Minsoo Kim, et al.Nature Chemical Biology|December 3, 2021
Apoptolidin family glycomacrolides target leukemia through inhibition of ATP synthaseBenjamin J Reisman, Hui Guo, Haley E Ramsey, et al.Proceedings of the National Academy of Sciences of the United States of America|March 31, 2026
Spirocyclic β-lactone secondary metabolites modulate spliceosome functionKathryn E Penton, Sydney A Bates, Hannah L Thirman, et al.ACS Chemical Biology|June 20, 2025
Photoaffinity Ligand of Cystic Fibrosis Corrector VX-445 Identifies SCCPDH as an Off-TargetMinsoo Kim, Kwangho Kim, Jesun Lee, et al.Nature Chemical Biology|July 22, 2020
Pharmacologic IRE1/XBP1s activation confers targeted ER proteostasis reprogrammingJulia M D Grandjean, Aparajita Madhavan, Lauren Cech, et al.Pageof 10